411 related articles for article (PubMed ID: 32760396)
21. Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care.
Francesqui J; Marrades P; Sellares J
Curr Opin Pulm Med; 2023 Sep; 29(5):478-484. PubMed ID: 37410487
[TBL] [Abstract][Full Text] [Related]
22. Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
Kalkanis A; Kalkanis D; Drougas D; Vavougios GD; Datseris I; Judson MA; Georgiou E
Nucl Med Commun; 2016 Mar; 37(3):273-7. PubMed ID: 26544095
[TBL] [Abstract][Full Text] [Related]
23. Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis.
Schoenberger CI; Line BR; Keogh BA; Hunninghake GW; Crystal RG
Thorax; 1982 Jan; 37(1):19-25. PubMed ID: 6280331
[TBL] [Abstract][Full Text] [Related]
24. Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis.
Kobayashi Y; Sato T; Nagai T; Hirata K; Tsuneta S; Kato Y; Komoriyama H; Kamiya K; Konishi T; Omote K; Ohira H; Kudo K; Konno S; Anzai T
ESC Heart Fail; 2021 Dec; 8(6):5282-5292. PubMed ID: 34514715
[TBL] [Abstract][Full Text] [Related]
25. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.
Keijsers RG; Verzijlbergen FJ; Oyen WJ; van den Bosch JM; Ruven HJ; van Velzen-Blad H; Grutters JC
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1131-7. PubMed ID: 19259660
[TBL] [Abstract][Full Text] [Related]
26. [Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis].
Baudin B
Pathol Biol (Paris); 2005 Apr; 53(3):183-8. PubMed ID: 15781381
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
Mostard RL; Vöö S; van Kroonenburgh MJ; Verschakelen JA; Wijnen PA; Nelemans PJ; Erckens RJ; Drent M
Respir Med; 2011 Dec; 105(12):1917-24. PubMed ID: 21899998
[TBL] [Abstract][Full Text] [Related]
28. Human chitotriosidase: a sensitive biomarker of sarcoidosis.
Bargagli E; Bennett D; Maggiorelli C; Di Sipio P; Margollicci M; Bianchi N; Rottoli P
J Clin Immunol; 2013 Jan; 33(1):264-70. PubMed ID: 22878841
[TBL] [Abstract][Full Text] [Related]
29. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
Specks U; Martin WJ; Rohrbach MS
Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and parameters for the evaluation of disease activity and prognosis in patients with pulmonary sarcoidosis].
Nagai S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):86-91. PubMed ID: 2162436
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis in sarcoidosis. Sensitivity and specificity of 67-gallium scintigraphy, serum angiotensin converting enzyme levels, thoracic radiography and blood lymphocyte subpopulations].
Klech H; Köhn H; Pohl W; Kummer F; Mostbeck A
Wien Med Wochenschr; 1983 Sep; 133(17):425-32. PubMed ID: 6314681
[TBL] [Abstract][Full Text] [Related]
32. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
33. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis.
Baughman RP; Shipley R; Eisentrout CE
Lung; 1987; 165(6):371-7. PubMed ID: 2828772
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis.
Miyata J; Ogawa T; Tagami Y; Sato T; Nagayama M; Hirano T; Kameyama N; Fukunaga K; Kawana A; Inoue T
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(1):8-16. PubMed ID: 33093764
[TBL] [Abstract][Full Text] [Related]
36. Bronchoalveolar lavage in sarcoidosis.
Chrétien J; Venet A; Danel C; Israel-Biet D; Sandron D; Arnoux A
Respiration; 1985; 48(3):222-30. PubMed ID: 2999931
[TBL] [Abstract][Full Text] [Related]
37. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
[TBL] [Abstract][Full Text] [Related]
38. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis.
Prior C; Barbee RA; Evans PM; Townsend PJ; Primett ZS; Fyhrquist F; Grönhagen-Riska C; Haslam PL
Eur Respir J; 1990 Nov; 3(10):1146-54. PubMed ID: 1965306
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers in sarcoidosis.
Chopra A; Kalkanis A; Judson MA
Expert Rev Clin Immunol; 2016 Nov; 12(11):1191-1208. PubMed ID: 27253883
[TBL] [Abstract][Full Text] [Related]
40. Chitotriosidase as a marker of disease activity in sarcoidosis.
Brunner J; Scholl-Bürgi S; Zimmerhackl LB
Rheumatol Int; 2007 Oct; 27(12):1171-2. PubMed ID: 17534622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
